PharmaCyte Biotech PMCB
NASDAQ PMCB
$0.52 +0.01 (+1.69%)
As of: Aug 21, 2026 · 2:51 PM EDT

PharmaCyte Biotech (PMCB) Gross Margin (QoQ) (2010 - 2012)

PharmaCyte Biotech (PMCB) Gross Margin (QoQ) (2010 - 2012) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.60 Bn 130.75 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.93 Bn 77.93 Bn 3.93 Bn
3 Argenx Se 65.06 Bn 59.88 Bn 1.37 Bn
4 Moderna 56.22 Bn 51.08 Bn 52.00 Mn
5 BeOne Medicines 42.03 Bn 36.93 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.65 Bn 28.34 Bn 992.69 Mn
7 BioNTech SE 27.70 Bn 9.31 Bn 668.28 Mn
8 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
9 Royalty Pharma 27.31 Bn 26.48 Bn -
10 PharmaCyte Biotech 4.38 Mn 4.38 Mn -

Historic Data

Download Data
DateValue
Oct 31, 2012 -15,301.00
Jul 31, 2012 -6,794.00
Apr 30, 2012 7,885.00
Jan 31, 2012 1,951.00
Oct 31, 2011 4,890.00
Jul 31, 2011 -7,865.00
Apr 30, 2011 6,797.00
Jan 31, 2011 -5,066.00
Oct 31, 2010 771.00